Bone metastases in breast cancer, prostate cancer and myeloma
Paterson, A.H.
Bone 8(Suppl 1): S17-S22
1987
ISSN/ISBN: 8756-3282 PMID: 3318889 Document Number: 294175
This paper reviews the skeletal complications of a variety of tumour types, with particular reference to the clinical problems which confront patients.
Document emailed within 1 workday
Related Documents
Zissimopoulos, A.; Stellos, K.; Matthaios, D.; Petrakis, G.; Parmenopoulou, V.; Babatsikou, F.; Matthaiou, E.; Theodosiadou, E.; Hountis, P.; Koutis, C. 2009: Type i collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy Journal of Buon: Official Journal of the Balkan Union of Oncology 14(3): 463-472Watanabe, A.; Taniguchi, M. 2005: A case of oropharyngeal cancer with multiple bone metastases from prostate cancer that responded to docetaxel, ifosfamide and cisplatin combination therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 65-67
Taguchi, T. 2011: Encounter of cancer cells with bone. Treatment of bone metastases from breast cancer Clinical Calcium 21(3): 429-438
Incorvaia, L.; Badalamenti, G.; Rini, G.; Arcara, C.; Fricano, S.; Sferrazza, C.; Di Trapani, D.; Gebbia, N.; Leto, G. 2007: MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone Anticancer Research 27(3b): 1519-1525
Saad, F.; Chi, K.; Fleshner, N. 2004: The role of bisphosphonates in the management of bone metastases in prostate cancer Canadian Journal of Urology 11(5): 2376-2382
Zhao, W.; Deng, H.; Jie, P.; Qing, C.; Zhang, X. 2010: Preliminary application of strontium-89 for the treatment of bone metastases from prostate cancer Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 27(6): 1251-1254
MJ Seibel; M Koeller; B van der Velden; I Diel 2002: Markers of Bone Turnover Do Not Predict Bone Metastases in Breast Cancer Clinical Laboratory 48(11-12): 583-588
Maruo, H.; Usui, Y. 2016: A Case of Synchronous Vp3 Hepatocellular Carcinoma and Prostate Cancer Accompanied by Bone Metastases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 1797-1799
Köhler, A.H.; Dobberstein, N.; Stoltmann, R.; Heschel, U. 1984: Therapy of bone metastases in breast cancer Zentralblatt für Chirurgie 109(7): 483-489
Heimpel, H. 1987: Treatment of bone metastases of breast cancer Deutsche Medizinische Wochenschrift 112(7): 286
Hortobagyi, G.N. 1991: Bone metastases in breast cancer patients Seminars in Oncology 18(4 Suppl 5: 11-15
Hayashi, N.; Yamauchi, H.; Nakamura, S. 2012: Management of bone metastases from breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(8): 1174-1177
Gasser, A.B.; Depierre, D.; Alberto, P.; Courvoisier, B. 1977: Hydroxyproline in the diagnosis of bone metastases in breast cancer Schweizerische Medizinische Wochenschrift 107(28): 984-986
Kohno, N. 2007: Bisphosphonate treatment against breast cancer with bone metastases Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 6): 575-581
Favini, G.; Arosio, A.; Libretti, A. 1979: Bone metastases from breast cancer treated with calcitonin. Case report Tumori 65(6): 713-717
Sanchakova, A.V.; Chernomordikova, M.F.; Tret'iakova, O.I.; Fadeev, N.P. 1979: Complex x-ray-radioisotope study in the diagnosis of bone metastases of breast cancer Vestnik Rentgenologii i Radiologii 21(3): 17-23
Kudoh, S.; Kawamura, H.; Suzuki, Y.; Matsuzaki, M.; Nishina, M.; Tsukamoto, M. 1996: Effectiveness of LH-RH agonist for bone metastases of breast cancer--report of a case Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 787-790
Theriault, R. 1996: Pamidronate in the treatment of osteolytic bone metastases in breast cancer patients British Journal of Clinical Practice. Suppl 87: 8
Korman, D.B.; Borisov, A.I.; Maslova, I.A.; Dobroskok, L.B. 1980: Use of adriablastine in the combined chemotherapy of breast cancer patients with bone metastases Voprosy Onkologii 26(8): 20-24
2016: Radium-223 (Ra-223) Re-Treatment (Re-tx): First Experience From an International, Multicenter, Prospective Study in Patients (Pts) With Castration-Resistant Prostate Cancer and Bone Metastases (mCRPC) Clinical Advances in Hematology and Oncology: H&o 14(4 Suppl. 5): 10-11